Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Alpha Metallurgical Resources, Inc., a mining company, produces, processes, and sells met and thermal coal in Virginia and West Virginia. As of December 31, 2021, it operated twenty active mines and eight coal preparation and load-out facilities. The company was formerly known as Contura Energy, Inc. and changed its name to Alpha Metallurgical Resources, Inc. in February 2021. Alpha Metallurgical Resources, Inc. was incorporated in 2016 and is headquartered in Bristol, Tennessee.

Alpha Metallurgical Resources, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

BRISTOL,TENN., OCT. 1, 2025 /PRNEWSWIRE/ -- ALPHA METALLURGICAL RESOURCES, INC. (NYSE: AMR), A LEADING U.S. SUPPLIER OF METALLURGICAL PRODUCTS FOR THE STEEL INDUSTRY, PLANS TO ANNOUNCE ITS THIRD QUARTER 2025 FINANCIAL RESULTS BEFORE THE MARKET OPENS ON THURSDAY, NOVEMBER 6, 2025.

ALPHA TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 6

BRISTOL,TENN., AUG. 26, 2025 /PRNEWSWIRE/ -- A MINE ELECTRICIAN WORKING AT THEMARFORK PREPARATION PLANT IN RALEIGH COUNTY, W.VA.

MINE ELECTRICIAN SUFFERS FATAL ACCIDENT

REPORTS SECOND QUARTER NET LOSS OF $5.0 MILLION POSTS ADJUSTED EBITDA OF $46.1 MILLION FOR THE QUARTER ACHIEVES TOTAL LIQUIDITY OF $556.9 MILLION AS OF JUNE 30 ACCOMPLISHES BEST QUARTERLY COST OF COAL SALES PERFORMANCE SINCE 2021; LOWERS 2025 COST OF COAL SALES GUIDANCE RANGE TO $101 PER TON TO $107 PER TON, DOWN FROM $103 PER TON TO $110 PER TON REDUCES SG&A GUIDANCE TO $48 MILLION TO $54 MILLION, DOWN FROM PRIOR RANGE OF $53 MILLION TO $59 MILLION INCREASES NET CASH INTEREST INCOME GUIDANCE TO $6 MILLION TO $12 MILLION, UP FROM PRIOR RANGE OF $2 MILLION TO $10 MILLION RAISES FULL YEAR GUIDANCE RANGE FOR IDLE OPERATIONS EXPENSE TO $21 MILLION TO $29 MILLION, UP FROM PREVIOUS RANGE OF $18 MILLION TO $28 MILLION BRISTOL,TENN., AUG. 8, 2025 /PRNEWSWIRE/ -- ALPHA METALLURGICAL RESOURCES, INC. (NYSE: AMR), A LEADING U.S. SUPPLIER OF METALLURGICAL PRODUCTS FOR THE STEEL INDUSTRY, TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDING JUNE 30, 2025.

ALPHA ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS

CID-103 IS A POTENTIAL BEST-IN-CLASS, ANTI-CD38 MONOCLONAL ANTIBODY; BINDS TO UNIQUE CD38 EPITOPE PHASE 1 STUDY IN ADULTS WITH ACTIVE AND CHRONIC ACTIVE RENAL ALLOGRAFT AMR PLANNED TO INITIATE AMR IS A LEADING CAUSE OF KIDNEY TRANSPLANT LOSS, LEADING TO DIALYSIS AND/OR REPEAT RENAL TRANSPLANT SAN FRANCISCO, CA / ACCESS NEWSWIRE / AUGUST 4, 2025 / CASI PHARMACEUTICALS, INC. (NASDAQ:CASI), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON DEVELOPING INNOVATIVE THERAPIES FOR PATIENTS WITH ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASES, TODAY ANNOUNCED FDA CLEARANCE OF AN IND APPLICATION FOR CID-103, AN ANTI-CD38 MONOCLONAL ANTIBODY IN ADULTS WITH ACTIVE AND CHRONIC ACTIVE RENAL ALLOGRAFT ANTIBODY MEDIATED REJECTION (AMR). THE PHASE 1 CLINICAL TRIAL IS A DOSE-RANGING AND SAFETY STUDY EVALUATING THE TOLERABILITY AND EFFICACY OF CID-103 IN PATIENTS WITH AMR.

CASI PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CID-103 IN RENAL ALLOGRAFT ANTIBODY-MEDIATED REJECTION (AMR)

BRISTOL, TENN. , JULY 8, 2025 /PRNEWSWIRE/ -- ALPHA METALLURGICAL RESOURCES, INC. (NYSE:AMR), A LEADING U.S. SUPPLIER OF METALLURGICAL PRODUCTS FOR THE STEEL INDUSTRY, PLANS TO ANNOUNCE ITS SECOND QUARTER 2025 FINANCIAL RESULTS BEFORE THE MARKET OPENS ON FRIDAY, AUGUST 8, 2025.

ALPHA TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 8

REPORTS FIRST QUARTER NET LOSS OF $33.9 MILLION POSTS ADJUSTED EBITDA OF $5.7 MILLION FOR THE QUARTER INCREASES SIZE OF ABL FROM $155 MILLION TO $225 MILLION THROUGH AMENDED AND EXTENDED AGREEMENT WITH NEW EXPIRATION OF MAY 2029 REDUCES METALLURGICAL COAL SALES VOLUME GUIDANCE RANGE TO 13.8 MILLION TO 14.8 MILLION TONS FOR THE YEAR; ADJUSTS DOWN RANGE OF THERMAL COAL SHIPMENT EXPECTATIONS TO 0.8 MILLION TO 1.2 MILLION TONS LOWERS 2025 CAPEX GUIDANCE RANGE TO $130 MILLION TO $150 MILLION BRISTOL,TENN., MAY 9, 2025 /PRNEWSWIRE/ -- ALPHA METALLURGICAL RESOURCES, INC. (NYSE: AMR), A LEADING U.S. SUPPLIER OF METALLURGICAL PRODUCTS FOR THE STEEL INDUSTRY, TODAY REPORTED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDING MARCH 31, 2025.

ALPHA ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS

BOWLING GREEN, KY.--(BUSINESS WIRE)--HOLLEY PERFORMANCE BRANDS (NYSE: HLLY), A LEADER IN AUTOMOTIVE AFTERMARKET PERFORMANCE SOLUTIONS, TODAY ANNOUNCED A STRATEGIC COLLABORATION WITH INDYCAR FOR THE 2025 RACE SEASON. THE COMPANY WILL OUTFIT ALL 30 MEMBERS OF THE AMR INDYCAR SAFETY TEAMINCLUDING PHYSICIANS, PARAMEDICS, FIREFIGHTERS, EMTS AND NURSESWITH TOP-RATED SIMPSON FIRE SUITS TO ENSURE THE HIGHEST STANDARDS OF PROTECTION. AS PART OF THIS INITIATIVE, THERE WILL ALSO BE SAFETY TRAINING THROU.

SIMPSON TO OUTFIT AMR INDYCAR SAFETY TEAM IN 2025 SEASON

CAMBRIDGE, MASS., MARCH 11, 2025 (GLOBE NEWSWIRE) -- BIOGEN INC.(NASDAQ: BIIB)  ANNOUNCED THE INITIATION OF DOSING IN THE GLOBAL CLINICAL STUDY, TRANSCEND. THE PHASE 3 STUDY WILL EVALUATE THE EFFICACY AND SAFETY OF THE INVESTIGATIONAL DRUG FELZARTAMAB COMPARED TO PLACEBO IN ADULT KIDNEY TRANSPLANT RECIPIENTS DIAGNOSED WITH LATE ANTIBODY-MEDIATED REJECTION (AMR). TRANSCEND IS DESIGNED TO ENROLL APPROXIMATELY 120 KIDNEY TRANSPLANT RECIPIENTS WITH LATE AMR.

BIOGEN INITIATES PHASE 3 STUDY OF FELZARTAMAB FOR THE TREATMENT OF LATE ANTIBODY-MEDIATED REJECTION (AMR) IN KIDNEY TRANSPLANT PATIENTS

REPORTS NET LOSS OF $2.1 MILLION FOR THE FOURTH QUARTER 2024 POSTS ADJUSTED EBITDA OF $53.2 MILLION FOR THE QUARTER REDUCES 2025 VOLUME GUIDANCE FOR METALLURGICAL COAL SHIPMENTS TO 14.5 MILLION TO 15.5 MILLION TONS INCREASES FULL-YEAR COST OF COAL SALES GUIDANCE RANGE TO $103.00 TO $110.00 PER TON REDUCED LETTERS OF CREDIT OUTSTANDING BY $15 MILLION DURING THE QUARTER BRISTOL, TENN. , FEB. 28, 2025 /PRNEWSWIRE/ -- ALPHA METALLURGICAL RESOURCES, INC. (NYSE: AMR), A LEADING U.S. SUPPLIER OF METALLURGICAL PRODUCTS FOR THE STEEL INDUSTRY, TODAY REPORTED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDING DECEMBER 31, 2024.

ALPHA ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024

BRISTOL,TENN., JAN. 23, 2025 /PRNEWSWIRE/ --ALPHA METALLURGICAL RESOURCES, INC. (NYSE:AMR), A LEADING U.S. SUPPLIER OF METALLURGICAL PRODUCTS FOR THE STEEL INDUSTRY, PLANS TO ANNOUNCE ITS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS BEFORE THE MARKET OPENS ON FRIDAY, FEBRUARY 28, 2025.

Alpha Metallurgical Resources, Inc.

AMR

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Alpha Metallurgical Resources, Inc.

AMR.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

AMR